# FDA recall Z-2869-2018

> **Becton Dickinson & Co.** · Class II · device recall initiated 2018-06-21.

## Product

BD BBL GC-Lect Agar; Cat. No. 297715     The device is a selective medium providing enhanced growth and recovery of Neisseria gonorrhoeae and better inhibition of contamination bacteria and fungi.

## Reason for recall

A portion of this lot was manufactured using Gentamicin instead of Vancomycin. Gentamicin is an inhibitory agent of Neisseria organisms. This  product is a selective plated medium to provide enhanced growth and recovery of N  gonorrhoeae. Inhibited growth may cause a false negative result or a delayed result leading to  incorrect or delayed treatment.

## Distribution

US Distribution in states of: AK, AL, AR, AZ, CA, CO, DC, DE, FL, GA, HI, ID, IN, KS, KY, MA, MI, MS, MT, NC, JH, NY, OK, OR, PA, SC, TN, TX, WA, and WI.

## Key facts

- **Recall number:** Z-2869-2018
- **Recalling firm:** Becton Dickinson & Co.
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2018-06-21
- **Report date:** 2018-08-29
- **Termination date:** 2019-07-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sparks, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2869-2018

## Citation

> AI Analytics. FDA recall Z-2869-2018. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/Z-2869-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*